Glaceum
Corporate brand
UnclaimedSouth Korean biopharmaceutical company developing innovative drugs for metabolic and rare diseases.
Last updated November 4, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Glaceum is a biopharmaceutical company headquartered in Suwon, South Korea. According to its official website, the company is dedicated to developing innovative new drugs for diseases caused by metabolic and cellular changes, with a focus on metabolic disorders and rare diseases. Its R&D pipeline centers on novel therapies addressing unmet medical needs in these areas. Although specific details about its founding, leadership, and financial status are not available in the existing evidence, Glaceum represents a member of South Korea's growing biotechnology sector, contributing to the development of advanced treatments for serious diseases.
History
Glaceum is a South Korean biopharmaceutical company based in Suwon. The company focuses on the research and development of innovative new drugs for metabolic diseases and rare diseases. Its work involves addressing diseases caused by metabolic and cellular changes. Specific historical milestones, such as founding date and early development, are not available in the provided evidence.
Products and positioning
Developer of innovative drugs for metabolic and rare diseases.
Sources2 sources
Cite this profile: Cite the canonical profile. /brand-wiki/glaceum-south-korea · Editorial policy · How profiles are compiled